tiprankstipranks
Trending News
More News >

Steven Robert Pacelli Insider Profile

4 Followers
Steven Robert Pacelli, EVP Managing Director Dexcom V at Dexcom, holds 124.78K shares in Dexcom (Ticker: DXCM), holds ― shares in ProSomnus (Ticker: OSAPQ).
tipranks
Steven Robert Pacelli

Steven Robert Pacelli
Dexcom (DXCM)
EVP Managing Director Dexcom V

Ranked #91,507 out of 100,956 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-39.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
A breakdown of Steven Robert Pacelli's holdings

Insider Roles

Dexcom
(DXCM)
EVP Managing Director Dexcom V
Roles that Steven Robert Pacelli holds in companies

Most Profitable Insider Trade

Stock:
Dexcom
(DXCM)
Rating:Informative Sell
Date:Nov 12, 2015 - Nov 12, 2016
Return:+21.80%
The most profitable trade made by Steven Robert Pacelli

Steven Robert Pacelli's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dexcom
Nov 27, 2023
EVP Managing Director Dexcom V
Uninformative Sell
45.54K
$9.71M
OSAPQ
ProSomnus
List of latest transactions for each holding click on a transaction to see Steven Robert Pacelli's performance on stock

Steven Robert Pacelli insider profile FAQ

What is the percentage of profitable transactions made by Steven Robert Pacelli?
The percentage of profitable transactions made by Steven Robert Pacelli is 20%.
    What is the average return per transaction made by Steven Robert Pacelli?
    The average return per transaction made by Steven Robert Pacelli is -39.70%.
      What stocks does Steven Robert Pacelli hold?
      Steven Robert Pacelli holds: DXCM, OSAPQ stocks.
        What was Steven Robert Pacelli’s latest transaction?
        Steven Robert Pacelli latest transaction was an Uninformative Sell of $45.54K.
          What was Steven Robert Pacelli's most profitable transaction?
          Steven Robert Pacelli’s most profitable transaction was an Informative Sell of DXCM stock on November 12, 2015. The return on the trade was 21.80%.
            What is Steven Robert Pacelli's role in Dexcom?
            Steven Robert Pacelli's role in Dexcom is EVP Managing Director Dexcom V.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.